Related Experiment Video
Updated: Dec 9, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Users' Adherence and Off-Label Use of HIV-Pre-Exposure Prophylaxis]
Christian Flössner1, Benjamin T Schleenvoigt2, Jens Abendroth1
1Institut für Allgemeinmedizin, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle.
Introduction:
HIV-PrEP (HIV-Pre-Exposure Prophylaxis) has been available through German pharmacies in various package sizes since 2017. It can be used for daily dosing or as an intermittent product used as required.
Aim:
The aim of this survey was to record socio-demographic basic characteristics, the respondents' medical history regarding STI (sexual transmitted infections), previous PEP (Post-exposure prophylaxis) use, the system of PrEP use, the prior diagnostics carried out as well as the advice regarding the use of PrEP and information on whether PrEP was passed on to others.
Method:
A cross-sectional analysis was carried out in the form of a revised, self-developed multiple-choice questionnaire for 515 users within the network of HIV-competent pharmacies.
Results:
Three-quarters of the exclusively male respondents were in the age group of 20-39 years. More than 80% used the PrEP according to recommendations. Approximately two-thirds had received PEP in the past. The same number also had, at least, one STI in previous years. The necessary previous diagnostics were mostly carried out; 7% of the PrEP is passed on to other users.
Conclusion:
The majority (approximately 2/3) of the PrEP users are high-risk users with regard to previous STI or previous PEP use, and use the PrEP according to recommendations. As a result of simpler prescribability and broader use, the importance of PrEP is expected to grow in future.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Therapeutic Drug Monitoring: Affecting Factors

